ReviewFrontiers in neuroscience2026
Application of neuromodulation techniques in irritable bowel syndrome.
Review in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Electroacupuncture-mediated lncRNA TUG1 regulates the miR-127-3p/NF-κB p65 axis to inhibit IBS-D low-grade intestinal inflammation.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Irritable bowel syndrome (IBS) is a gut-brain interaction disorder characterized by abdominal pain/abdominal discomfort accompanied by changes in bowel motility. Its pathogenesis involves the interaction of multiple factors, including abnormalities of the brain-gut axis, intestinal microbiota dysbiosis, and visceral hypersensitivity. Traditional treatment strategies mainly focus on symptomatic relief, which have limitations such as insufficient targeting and significant side effects. Neuromodulation techniques, as an emerging treatment modality, modulate the central or peripheral nervous system through electrical and electromagnetic means, targeting key pathways of the brain-gut axis. These techniques can regulate gut motility and suppress inflammatory responses, thereby alleviating IBS symptoms. Currently, several techniques are widely applied, including electroacupuncture (EA), Sacral Nerve Stimulation (SNS), transcutaneous auricular vagus nerve stimulation (taVNS), and transcutaneous electrical nerve stimulation (TENS). Multiple clinical trials have confirmed their effectiveness in relieving abdominal pain, improving bowel dysfunction, and enhancing quality of life. However, there are still issues such as significant individual differences and insufficient long-term efficacy data. Future research should focus on the development of personalized treatment plans, exploration of combination therapy strategies, and technological innovation to further enhance their clinical value.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.